Skip to main content
Equibles
RMTI logo

RMTI · Rockwell Medical, Inc.

Track RMTI — free

Use RMTI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RMTI

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.41 -0.42 (-5.30%) At close · Aug 14
Market Cap
$296.42M
Shares
4.03M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$7.41 Open$7.70 Day$7.36–7.70 Since split$5.19–7.83 Avg vol 30d34K Short int99K · 2.4% float · 3.0d Short vol29% Last earningsAug 13, 2026 DataJul 2026–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Jul 1, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jul 1, 2026.

Up next

Next earnings call
Nov 15, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Limited Sentiment Bearish Fundamentals Weak Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      RSI (14) 63
      neutral
      52-week position 84%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Limited
      Not enough data for a confident read.
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Distributing
      -16% holders QoQ · +7 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      2.44% of float · ▲ +15.2% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      36 holders — mid 3-yr range
      Squeeze score 70
      elevated · 0–100
      Fundamentals
      Weak
      Revenue growth −32%
      Y/Y
      Gross margin 17%
      contracting
      EPS growth −400%
      Y/Y
      Balance sheet $1.9M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 60%
      annualized · 1-yr
      Max drawdown −10%
      past year
      ATR 6.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Aug 13, 2026
      full year 2026
      Gross margin Initiated 18% – 22%
      Adjusted EBITDA Initiated $1M – $2M
      Net sales Initiated $70M – $75M
      prior FY $69.26M midpoint +4.7% Y/Y
      by 2029
      Annual net sales at least $100M
      prior FY $69.26M midpoint +44.4% Y/Y
      Prior guidance period ended · from the 8-K filed Nov 12, 2025
      Gross Margin · 2025 Annual Guidance 16% – 18%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      0 · 4 · 0
      50 / 200-day cross
      No cross Neutral
      RSI (14)
      63 Neutral
      52-week position
      84% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Distributing
      -16% holders QoQ · +7 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      2.44% of float · ▲ +15.2% MoM · 3.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      36 holders — mid 3-yr range
      Price context
      position in its range since split · 2026-07-01
      Range low $5 Now $7 · 84% Range high $8

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Drug Manufacturers - Specialty & Generic — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RMTI
      Rockwell Medical, Inc.
      this stock
      		$296.42M — -31.8% — 2.4%
      TAK
      Takeda Pharmaceutical Co Ltd
      		 $55.60B +13.1% — — 0.1%
      GALDY
      Galderma Group AG/ADR
      		 $49.59B +2.4% — — 0.0%
      JHPCY
      Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
      		 $45.13B — — — 0.0%
      HLN
      Haleon plc
      		 $43.16B -4.1% — — 0.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      36
      % held
      8.5%
      Net QoQ
      -57.7K sh
      Top holder
      VANGUARD CAPITAL MANAGEME…
      Held Float
      View
      Held by Funds
      Fund positions
      6
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      98.5K
      Days to cover
      3.0d
      Change
      +13.0K sh
      View
      Short Volume
      Short vol %
      29%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.4K
      Value
      $13.6K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      46.0%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Net income (FY)
      $-5.3M
      EPS diluted
      $-1.50
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 13, 2026
      This year
      16
      View
      Proposed Sales
      Value
      $712
      Shares
      886
      Filed
      Jan 5, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 13, 2026
      View
      Investor Relations
      Latest news
      Rockwell Medical Advances Quality…
      Published
      Jul 22, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Jul 1, 2026; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      RMTI +3.8% +20.9% — +3.1% —
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +3.4% +16.4% — -0.9% —
      Key facts CIK 1041024 CUSIP 774374409 13F (30d) 36 filings 36 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)